BARBARA NAMAN: Open Payments
NPI 1487975710 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 17 payments from 7 companies in 2025. Trend: 2023 $493 · 2024 $1,187 · 2025 $357
Food & beverage: $357
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $231 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| EVOKE PHARMA, INC. | 1 | $20 |
| Gilead Sciences, Inc. | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $8 |
Products named: CREON, LINZESS, DUPIXENT, ENTYVIO, SKYRIZI, GIMOTI, VOWST, VOQUEZNA.
Industry payments across AL — which companies pay providers there.
